Vimarsana
Biggest News Aggregation in the World

Page 9 - Seed Financing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Seed Financing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Seed Financing Today - Breaking & Trending Today

Tynt Technologies Secures $8.5 Million in Seed Funding for Groundbreaking Technology behind Blackout Dynamic Windows - Vimarsana News

Tynt Technologies Secures $8.5 Million in Seed Funding for Groundbreaking Technology behind Blackout Dynamic Windows

/PRNewswire/ -- Tynt Technologies, Inc. (Tynt), a Colorado-based dynamic window company that's engineering the first ever blackout dynamic window, announced it...

Portuguese Medical Cannabis Company AceCann Raises $15 Million - Vimarsana News

Portuguese Medical Cannabis Company AceCann Raises $15 Million

AceCann Closes $15M in Seed Financing to Produce First Premium, Organic Flower and Extracts for Europe. Funding accelerates development of a state-of-the-art... #AceCann #casaverde #LinceCapital

Sirnaomics' Spin-Off RNAimmune Secures $10 Million Seed Financing to Advance its mRNA-Based Vaccine and Therapeutic Development | Vaccines - Vimarsana News

Sirnaomics' Spin-Off RNAimmune Secures $10 Million Seed Financing to Advance its mRNA-Based Vaccine and Therapeutic Development | Vaccines

Hits: 137 GAITHERSBURG, MD, USA and GUANGZHOU, China I April 21, 2021 I RNAimmune, Inc., a biopharmaceutical company specializing in discovery and development of mRNA-based therapeutics and vaccines, announced today execution of definitive agreements for a seed round financing of $10 million. RNAimmune is a spin-off entity from Sirnaomics, a biopharmaceutical company engaged in the discovery and development of RNAi therapeutics against cancer and fibrotic diseases. Smooth River and Hong Kong Hongrun led the investment, with participation from Shanghai Walga Biotechnology, High Forest Inve...

4BIO Capital Co-leads $10 Million Seed Financing in Code Biotherapeutics - Vimarsana News

4BIO Capital Co-leads $10 Million Seed Financing in Code Biotherapeutics

4BIO Capital Co-leads $10 Million Seed Financing in Code Biotherapeutics 04/20/2021 | 09:00am EDT Send by mail : Message : 20 April 2021 LONDON & BOSTON – 4BIO Capital (“4BIO” or “the Group”), an international venture capital firm focused solely on the advanced therapies sector, today announces that it has co-led a $10 million Seed financing round in Code Biotherapeutics, Inc. (“Code Bio” or the ”Company”), a next generation gene therapy company pioneering the development of targeted non-viral gene therapies for rare and prevalent genetic diseases. 4BIO actively participated...

4Bio Capital: 4BIO Capital Co-leads $10 Million Seed Financing in Code Biotherapeutics - Vimarsana News

4Bio Capital: 4BIO Capital Co-leads $10 Million Seed Financing in Code Biotherapeutics

4Bio Capital: 4BIO Capital Co-leads $10 Million Seed Financing in Code Biotherapeutics 20 April 2021 LONDON & BOSTON - 4BIO Capital ("4BIO" or "the Group"), an international venture capital firm focused solely on the advanced therapies sector, today announces that it has co-led a $10 million Seed financing round in Code Biotherapeutics, Inc. ("Code Bio" or the "Company"), a next generation gene therapy company pioneering the development of targeted non-viral gene therapies for rare and prevalent genetic diseases. 4BIO actively participated in the start-up process and co-led the financing alon...